RecruitingNCT07191223

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners and Specialists in Endemic Areas and Outside Endemic Areas in France


Sponsor

University Hospital, Strasbourg, France

Enrollment

100 participants

Start Date

Feb 16, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Tick-borne encephalitis is a relatively rare disease (approximately 35 cases diagnosed per year), but most cases (86%) are due to contamination in France via a tick bite. Of the 71 cases reported over two years (May 2021 to May 2023), 94% of patients were hospitalized. It is therefore important to consider and diagnose at the first signs to ensure appropriate follow-up and also to implement primary prevention in endemic/at-risk areas.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Be a doctoral student or in training
  • Practice in France
  • Agree to participate in the survey.

Exclusion Criteria1

  • \- Refusal to participate in the study

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Service des maladies infectieuses et tropicales - CHU de Strasbourg - France

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07191223